Ozdemir Mehmet Akif, Karakukcu Musa, Per Huseyin, Unal Ekrem, Gumus Hakan, Patiroglu Turkan
Division of Pediatric Hematology and Oncology, Department of Pediatrics, Faculty of Medicine, Erciyes University, Talas, Kayseri, Turkey.
Childs Nerv Syst. 2012 Feb;28(2):247-51. doi: 10.1007/s00381-011-1575-x. Epub 2011 Sep 18.
Deficiency of vitamin K predisposes to early, classic, or late vitamin K deficiency bleeding (VKDB), of which late VKDB may be associated with serious and life-threatening intracranial bleeding. Late VKDB is characterized with intracranial bleeding in infants aged 2-24 weeks due to severe vitamin K deficiency, occurring primarily in exclusively breast-fed infants. Late VKDB is still an important cause of mortality and morbidity in developing countries.
We presented 120 cases of late VKDB, which were evaluated at Erciyes University Medical Faculty Hospital between June 1990 and June 2006.
Signs and symptoms of the patients were bulging fontanels (70%); irritabilities (50%); convulsions (49%); bleeding and ecchymosis (47%); feeding intolerance, poor sucking, and vomiting (46%); diarrhea (34%); jaundice (11%); and pallor (9%), and among these infants, 21% received medication before the diagnosis (10%, antibiotics; 3%, simethicone; 4%, paracetamol; and 4%, phenobarbital). Intracranial hemorrhage in 88 (73%) patients has been observed. The hemorrhage was subdural in 34 (28%) cases, intracerebral in 28 (23%), subarachnoid in 17 (14%), intraventricular in 9 (8%), intracerebral and subdural in 12 (10%), subdural and subarachnoid in 6 (5%), and combination of intracerebral, subdural, and intraventricular in 14 (12%), and the mortality rate was 31%.
Although late VKDB leads to significant morbidity and mortality, it can be avoided by providing vitamin K prophylaxis to all newborns. Administration of vitamin K (1 mg) at birth can prevent intracranial bleeding and other hemorrhagic manifestations.
维生素K缺乏易导致早期、典型或晚期维生素K缺乏性出血(VKDB),其中晚期VKDB可能与严重且危及生命的颅内出血有关。晚期VKDB的特征是由于严重维生素K缺乏,在2至24周龄婴儿中发生颅内出血,主要发生在纯母乳喂养的婴儿中。晚期VKDB仍然是发展中国家死亡率和发病率的重要原因。
我们报告了120例晚期VKDB病例,这些病例于1990年6月至2006年6月在埃尔西耶斯大学医学院医院进行了评估。
患者的体征和症状包括囟门隆起(70%);易激惹(50%);惊厥(49%);出血和瘀斑(47%);喂养不耐受、吸吮无力和呕吐(46%);腹泻(34%);黄疸(11%);以及苍白(9%),在这些婴儿中,21%在诊断前接受过药物治疗(10%为抗生素;3%为西甲硅油;4%为对乙酰氨基酚;4%为苯巴比妥)。观察到88例(73%)患者发生颅内出血。出血类型为硬膜下出血34例(28%),脑内出血28例(23%),蛛网膜下腔出血17例(14%),脑室内出血9例(8%),脑内和硬膜下出血12例(10%),硬膜下和蛛网膜下腔出血6例(5%),脑内、硬膜下和脑室内出血联合存在14例(12%),死亡率为31%。
尽管晚期VKDB会导致显著的发病率和死亡率,但通过为所有新生儿提供维生素K预防措施可以避免。出生时给予维生素K(1mg)可预防颅内出血和其他出血表现。